Case study: breakthrough mpox infection in Aotearoa New Zealand and Australia after completed two-dose course of subcutaneous modified vaccinia Ankara (MVA-BN) vaccines
Cornelisse, Vincent J, Kearley, John J M, Vargas Castillo, Jose, Macharg, Lindsay, McLaughlin, Virginia A, Jack, Susan J, Swift, Caitlin
Published in Sexual health (01.12.2023)
Published in Sexual health (01.12.2023)
Get full text
Journal Article
Treatment adherence and support for people who inject drugs taking direct‐acting antiviral therapy for hepatitis C infection
Read, Phillip, Gilliver, Rosie, Kearley, John, Lothian, Rebecca, Cunningham, Evan B., Chronister, Karen J., Dore, Gregory J.
Published in Journal of viral hepatitis (01.11.2019)
Published in Journal of viral hepatitis (01.11.2019)
Get full text
Journal Article
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Read, Phillip, Lothian, Rebecca, Chronister, Karen, Gilliver, Rosie, Kearley, John, Dore, Gregory J, van Beek, Ingrid
Published in The International journal of drug policy (01.09.2017)
Published in The International journal of drug policy (01.09.2017)
Get full text
Journal Article
Findings and lessons learnt from implementing Australia's first health service based take‐home naloxone program
Chronister, Karen J., Lintzeris, Nicholas, Jackson, Anthony, Ivan, Mihaela, Dietze, Paul M., Lenton, Simon, Kearley, John, van Beek, Ingrid
Published in Drug and alcohol review (01.05.2018)
Published in Drug and alcohol review (01.05.2018)
Get full text
Journal Article
Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low‐threshold primary health‐care opioid agonist treatment program
Chronister, Karen J., Lothian, Rebecca, Gilliver, Rosie, Kearley, John, Read, Phillip
Published in Drug and alcohol review (01.02.2019)
Published in Drug and alcohol review (01.02.2019)
Get full text
Journal Article